NOVO NORDISK v. CARACO PHARMACEUTICAL LABS.

No. 2011-1223.

719 F.3d 1346 (2013)

NOVO NORDISK A/S and Novo Nordisk Inc., Plaintiffs-Appellants, v. CARACO PHARMACEUTICAL LABORATORIES, LTD. and Sun Pharmaceutical Industries, Ltd., Defendants-Appellees.

United States Court of Appeals, Federal Circuit.

June 18, 2013.


Attorney(s) appearing for the Case

Mark A. Perry , Gibson, Dunn & Crutcher LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were Josh A. Krevitt , Wayne Barsky , and Micheal A. Sitzman. Of counsel was Lucas C. Townsend.

James F. Hurst , Winston & Strawn LLP, of Chicago, IL, argued for defendants-appellees. With him on the brief were David S. Bloch , Charles B. Klein , Steffen N. Johnson and Andrew C. Nichols. Of counsel was John K. Hsu.

Opinion for the court filed by Circuit Judge PROST. Opinion concurring in part and dissenting in part filed by Circuit Judge NEWMAN.


PROST, Circuit Judge.

Novo Nordisk A/S and Novo Nordisk Inc. ("Novo") appeal a decision of the United States District Court for the Eastern District of Michigan which held that claim 4 of U.S. Patent No. 6,677,358 ("'358 patent") was invalid as obvious and that the '358 patent was unenforceable due to inequitable conduct. See Novo Nordisk A/S v. Caraco Pharm. Labs., 775 F.Supp.2d 985, 1025 (E.D.Mich.2011). For the reasons...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases